Bank of America’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-59
Closed -$53 8536
2024
Q2
$53 Buy
+59
New +$68 ﹤0.01% 7828
2024
Q1
Sell
-99
Closed -$114 8296
2023
Q4
$114 Buy
+99
New +$132 ﹤0.01% 7408
2023
Q1
Sell
-8
Closed -$21 8400
2022
Q4
$21 Buy
+8
New +$44 ﹤0.01% 7979
2022
Q1
Hold
0
8906
2021
Q4
Sell
-341
Closed -$8.04K 8771
2021
Q3
$6K Buy
+341
New +$6.4K ﹤0.01% 7707

Other funds holding BTCY

Bank of America's BTCY Position: Q3 2024 in Review

Bank of America sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 59 shares — an estimated $53 sold.

Bank of America first reported a position in BTCY in Q3 2021 and held it in 4 quarters. The position peaked at $6K in Q3 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • Bank of America reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Bank of America sold 59 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $53.
  • Bank of America first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Bank of America's Biotricity, Inc. Common Stock position peaked at $6K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.